Old Web
English
Sign In
Acemap
>
Paper
>
PCV22 COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN/AMLODIPINE FIX-DOSE COMBINATION FOR HYPERTENSIVE PATIENTS IN CHINA
PCV22 COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN/AMLODIPINE FIX-DOSE COMBINATION FOR HYPERTENSIVE PATIENTS IN CHINA
2019
J Xuan
Y. Lu
D. Xuan
Y. Fu
Keywords:
Cost-effectiveness analysis
Intensive care medicine
Olmesartan
Amlodipine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]